1. Home
  2. PCRX vs PLPC Comparison

PCRX vs PLPC Comparison

Compare PCRX & PLPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • PLPC
  • Stock Information
  • Founded
  • PCRX 2006
  • PLPC 1947
  • Country
  • PCRX United States
  • PLPC United States
  • Employees
  • PCRX N/A
  • PLPC N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • PLPC Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • PCRX Health Care
  • PLPC Industrials
  • Exchange
  • PCRX Nasdaq
  • PLPC Nasdaq
  • Market Cap
  • PCRX 1.2B
  • PLPC 616.6M
  • IPO Year
  • PCRX 2011
  • PLPC N/A
  • Fundamental
  • Price
  • PCRX $26.59
  • PLPC $142.50
  • Analyst Decision
  • PCRX Buy
  • PLPC
  • Analyst Count
  • PCRX 10
  • PLPC 0
  • Target Price
  • PCRX $29.30
  • PLPC N/A
  • AVG Volume (30 Days)
  • PCRX 892.8K
  • PLPC 35.1K
  • Earning Date
  • PCRX 02-27-2025
  • PLPC 03-06-2025
  • Dividend Yield
  • PCRX N/A
  • PLPC 0.55%
  • EPS Growth
  • PCRX N/A
  • PLPC N/A
  • EPS
  • PCRX N/A
  • PLPC 6.65
  • Revenue
  • PCRX $694,957,000.00
  • PLPC $572,200,000.00
  • Revenue This Year
  • PCRX $5.14
  • PLPC N/A
  • Revenue Next Year
  • PCRX $2.44
  • PLPC N/A
  • P/E Ratio
  • PCRX N/A
  • PLPC $21.63
  • Revenue Growth
  • PCRX 4.40
  • PLPC N/A
  • 52 Week Low
  • PCRX $11.16
  • PLPC $109.01
  • 52 Week High
  • PCRX $31.67
  • PLPC $154.90
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 77.75
  • PLPC 63.16
  • Support Level
  • PCRX $25.06
  • PLPC $120.76
  • Resistance Level
  • PCRX $27.10
  • PLPC $154.90
  • Average True Range (ATR)
  • PCRX 1.45
  • PLPC 4.92
  • MACD
  • PCRX 0.28
  • PLPC 2.10
  • Stochastic Oscillator
  • PCRX 86.23
  • PLPC 65.85

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About PLPC Preformed Line Products Company

Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. In addition, it provides solar hardware systems and mounting hardware for a variety of solar power applications. Its products consist of Energy Products, Communications Products, and Special Industries Products. The company's majority of the revenue is derived from the sale of products in The Americas with operations also in PLP-USA, Europe, the Middle East and Africa, and Asia-Pacific. The revenue gets driven by Energy products which comprise protecting transmission conductors, spacers, spacer-dampers, and Stockbridge dampers.

Share on Social Networks: